← Leaderboards
Yingjie Chen
University Of Mississippi Med Ctr
$8,599,988
Attributed
$8,599,988
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $868.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,599,988 · 7
By mechanism
R01$7,354,238 · 4
R21$1,245,750 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayInnovationGenesHeart FailureCardiacCongestive Heart FailureAttenuatedCessation Of LifeProductionInsightLungPathway InteractionsHeartCardiovascular DiseasesLeftCardiovascular SystemMediatingCellsFunctional DisorderRegulationMolecularMouse StrainsProteinsStress
Grant awards (22)
Mechanism of PD1 on cardiac inflammation resolution during heart failure development$581,250
R01 · FY2025 · HL · contact PI
Mechanism of PD1 on cardiac inflammation resolution during heart failure development$569,625
R01 · FY2024 · HL · contact PI
Mechanism of PD1 on cardiac inflammation resolution during heart failure development$581,250
R01 · FY2023 · HL · contact PI
Mechanism of PD1 on cardiac inflammation resolution during heart failure development$574,650
R01 · FY2022 · HL · contact PI
Mechanisms of Treg and IL-35 in Regulating LV Failure-induced Lung Remodeling and Right Heart Hypertrophy$549,819
R01 · FY2021 · HL · contact PI
Mechanisms of Treg and IL-35 in Regulating LV Failure-induced Lung Remodeling and Right Heart Hypertrophy$548,169
R01 · FY2020 · HL · contact PI
Mechanisms of Treg and IL-35 in Regulating LV Failure-induced Lung Remodeling and Right Heart Hypertrophy$570,673
R01 · FY2019 · HL · contact PI
Mechanisms of Treg and IL-35 in Regulating LV Failure-induced Lung Remodeling and Right Heart Hypertrophy$570,673
R01 · FY2018 · HL · contact PI
Molecular mechanism of 4E-binding proteins on heart failure development$369,950
R01 · FY2014 · HL · contact PI
Molecular mechanism of 4E-binding proteins on heart failure development$359,380
R01 · FY2013 · HL · contact PI
Molecular mechanism of 4E-binding proteins on heart failure development$377,500
R01 · FY2012 · HL · contact PI
Regulation of the novel mTOR suppressor DDIT4 in the failing heart$188,750
R21 · FY2012 · HL · contact PI
Molecular mechanism of 4E-binding proteins on heart failure development$377,500
R01 · FY2011 · HL · contact PI
Regulation of the novel mTOR suppressor DDIT4 in the failing heart$226,500
R21 · FY2011 · HL · contact PI
DDAH1 effects on endogenous NOS inhibitors and vascular endothelial function$151,000
R21 · FY2011 · HL · contact PI
DDAH1 effects on the development of congestive heart failure$113,250
R21 · FY2011 · HL · contact PI
DDAH1 effects on the development of congestive heart failure$302,000
R21 · FY2010 · HL · contact PI
DDAH1 effects on endogenous NOS inhibitors and vascular endothelial function$264,250
R21 · FY2010 · HL · contact PI
Nitric oxide and superoxide effects on the failing heart$326,274
R01 · FY2006 · HL · contact PI
Nitric oxide and superoxide effects on the failing heart$334,125
R01 · FY2005 · HL
Nitric oxide and superoxide effects on the failing heart$334,125
R01 · FY2004 · HL
Nitric oxide and superoxide effects on the failing heart$329,275
R01 · FY2003 · HL